These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16818456)

  • 21. Adriamycin-induced myocardial toxicity: new solutions for an old problem?
    Outomuro D; Grana DR; Azzato F; Milei J
    Int J Cardiol; 2007 Apr; 117(1):6-15. PubMed ID: 16863672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model.
    Xiang P; Deng HY; Li K; Huang GY; Chen Y; Tu L; Ng PC; Pong NH; Zhao H; Zhang L; Sung RY
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):343-9. PubMed ID: 18379782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dexrazoxane and amifostine on evolution of Doxorubicin cardiomyopathy in vivo.
    Bjelogrlic SK; Radic J; Radulovic S; Jokanovic M; Jovic V
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1414-24. PubMed ID: 18040065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doxorubicin in experimental and clinical heart failure.
    Christiansen S; Autschbach R
    Eur J Cardiothorac Surg; 2006 Oct; 30(4):611-6. PubMed ID: 16901709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced cardiomyopathies.
    Buja LM; Ferrans VJ; Roberts WC
    Adv Cardiol; 1974; 13():330-48. PubMed ID: 4615583
    [No Abstract]   [Full Text] [Related]  

  • 26. Doxorubicin cardiotoxicity in the elderly: old drugs and new opportunities.
    Carver JR; Schuster SJ; Glick JH
    J Clin Oncol; 2008 Jul; 26(19):3122-4. PubMed ID: 18591552
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of mtDNA lesions in anthracycline cardiotoxicity.
    Lebrecht D; Walker UA
    Cardiovasc Toxicol; 2007; 7(2):108-13. PubMed ID: 17652814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiotoxic effects of chemicals.
    Horowitz SF; Matza D; Machac J
    Mt Sinai J Med; 1985 Oct; 52(8):650-5. PubMed ID: 3878468
    [No Abstract]   [Full Text] [Related]  

  • 29. Doxorubicin cardiomyopathy: underlying cause of interferon-induced cardiac dysfunction?
    Geffen DB; Liel-Cohen N
    Isr Med Assoc J; 2007 Sep; 9(9):690; author reply 690-1. PubMed ID: 17939640
    [No Abstract]   [Full Text] [Related]  

  • 30. [Nephrotoxicity of antineoplastic agents (antibiotics)].
    Nakahama H
    Ryoikibetsu Shokogun Shirizu; 1997; (16 Pt 1):539-41. PubMed ID: 9277810
    [No Abstract]   [Full Text] [Related]  

  • 31. Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma.
    Hershman DL; McBride RB; Eisenberger A; Tsai WY; Grann VR; Jacobson JS
    J Clin Oncol; 2008 Jul; 26(19):3159-65. PubMed ID: 18591554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure.
    van der Putten K; Braam B; Jie KE; Gaillard CA
    Nat Clin Pract Nephrol; 2008 Jan; 4(1):47-57. PubMed ID: 18094727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human erythropoietin reduces epithelial cell apoptosis and attenuates bleomycin-induced pneumonitis in mice.
    Yoshimi M; Maeyama T; Yamada M; Hamada N; Fukumoto J; Kawaguchi T; Kuwano K; Nakanishi Y
    Respirology; 2008 Sep; 13(5):639-45. PubMed ID: 18713087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposomal doxorubicin-associated acute hypersensitivity despite appropriate preventive measures.
    Chan A; Shih V; Tham Chee Kian
    J Oncol Pharm Pract; 2007 Jun; 13(2):105-7. PubMed ID: 17873110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accidental anthracycline extravasation.
    Held-Warmkessel J
    Nursing; 2007 Dec; 37(12 Pt.1):72. PubMed ID: 18090648
    [No Abstract]   [Full Text] [Related]  

  • 36. Cutaneous recall phenomenon at the site of previous doxorubicin extravasation after second-line chemotherapy.
    Valencak J; Troch M; Raderer M
    J Natl Cancer Inst; 2007 Jan; 99(2):177-8. PubMed ID: 17228004
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prevention of cardiotoxic effects of anthracyclines in oncopediatric praxis].
    Safonova SA; Gershanovich ML; Punanov IuA
    Vopr Onkol; 2006; 52(5):590-2. PubMed ID: 17168373
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful bridge to transplant in a highly sensitized patient with a complicated pump pocket infection.
    McGee EC; Cotts W; Tambur AR; Friedewald J; Kim J; O'Connell J; Wallace S; McCarthy PM
    J Heart Lung Transplant; 2008 May; 27(5):568-71. PubMed ID: 18442726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiotoxic side effects of adriamycin].
    Brockmann B; Matthias M
    Z Arztl Fortbild (Jena); 1983; 77(5):209-11. PubMed ID: 6858220
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemotherapy-induced subacute lupus erythematosus.
    Guhl G; Diaz-Ley B; García-García C; Fraga J; Garcia-Diez A
    Lupus; 2009 Aug; 18(9):859-60. PubMed ID: 19578115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.